Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-032867

Director sold 8,000 shares at $19.34 ($154,720)

  • Director acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CHESS ROBERT · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-12 Exercise or conversion : show line 1 in the form +8,000 $13.80 $110,400 288,573 D
2021-05-12 Sale : show line 2 in the form −8,000 $19.34 $154,720 280,573 D
Open-market sales · 8,000 sh · avg $19.34 · $154,720

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-12 Exercise or conversion : show line 3 in the form Stock Option −8,000 24,000 D
Loading xslF345X03/doc4.xml…